... intraocular sur-
gery. Ophthalmology 98 :22 7 22 8, 1991.
24 . Peyman, G. A., and Schulman, J. A. Intravitreal drug therapy. In: Intravitreal
Surgery. Norwalk: Appleton-Century-Crofts, pp. 407–455.
25 . Speaker, ... Sci. 26 :698–710, 1985.
17. Lund-Andersen, H., Krogsaa, B., and Larsen, J. Calculation of the perme-
ability of the blood-retinal barrier to fluorescein. Graef. Arch. Clin. Ex...
... at 4, 12, and 24 hours after injection,
increased as the drug diffusivity was reduced. Furthermore, the rate of
drug elimination, which is inversely related to the drug s elimination half-
life, ... Ophthalmol. 22 8:461–466, 1990.
36. Tsukahara, Y., and Maurice, D. M., Local pressure effects on vitreous
kinetics. Exp. Eye Res. 60:563–574, 1995.
Drug Distribution in Vitreous Humor 22 1...
... applied drugs in the rabbit. Pharm. Res. 15:18 82 1887, 1998.
50. Yen, W C., and Lee, V. H. L. Role of Na
+
in the asymmetric paracellular
transport of 4-phenylazobenzyloxycarbonyl-L-Pro-L-Leu-Gly-L-Pro-D-Arg
across ... hydrocortisone/
hydroxypropyl-beta-cyclodextrin solution for ocular drug delivery. Int. J.
Pharm. 156 :20 1 20 9, 1997.
26 . Jarho, P., Jarvinen, K., Urtti, A., Stella, V....
... rhodop-
sin mutation were protected from apoptosis by recombinant adeno-
associated virus-mediated production of fibroblast growth factors fgf -2 ,
fgf-5, and fgf-18 (30,31), while lens epithelium-derived ... Atursson, P. (1990). Absorption of vasopressin analogue, 1-
desamino-8-D-arginine-vasopressin (dDAVP), in human intestinal epithelial
cell line, CaCO -2 , Int. J. Pharm., 64:181.
43....
... Blood, 83:677–6 82.
25 2. M. F. Kubik, A. W. Stephens, D. Schneider, R. A. Marlar, and D. Tasset.
(1994). High-affinity RNA ligands to human alpha-thrombin. Nucleic Acids
Res., 22 :26 19 26 26.
25 3. V. Nobile, ... 26 4:650–666.
24 2. L. R. Paborsky, S. N. McCurdy, L. C. Griffin, J. J. Toole, and L. C. Leung.
(1993). The single-stranded DNA aptamer-binding site of human thrombin. J.
Biol. Ch...